SEC Form 4 · accession 0001387131-15-003502
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Scott Slakter
Officer — Chief Executive Officer · Director
Period of report
Nov 20, 2015
Accepted (ET)
Nov 24, 2015 · 1:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1 | Nov 20, 2015 | J | 428,223 | — | A | 506,146 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution from a limited liability company. The shares were previously owned indirectly by the reporting person.